Skip to main content

Table 1 Review of publications including at least 20 patients

From: Management of the axilla for ipsilateral breast cancer recurrence after previous sentinel lymph node biopsy and breast conserving therapy

Author

N

Initial ALND/SLNB/none

Radiotracer injection

Detection (%)

SN axillary/extraaxillary

SN pos (%)

Palit 2008 (review) [22]

287

77/131/0

Review

73

n.a./32%

15

Van der Ploeg 2010 [24]

115

12/36/67

Intratumoral

83

70%/51%

12/115 (10)

Port 2007a [19]

117

63/54/0

Peritumoralc

55

69%/30%

10/64 (16)

Intra 2007a [20]

65

0/65/0

Peritumoral

97

97%/8%

7/65 (11)

Cox 2008 [38]

56

0/56/0

Periareolar / peritumoral

80

98%/2%

9/45 (20)

Axelsson 2008 [12]

47

43/1/3

Peritumorald

45

24/7

7/20 (35)

Koizumi 2008 [9]

31

16/3/12

Peritumoral

95

61%/36%

4/28 (14)

Schrenk 2008 [15]

23

12/11/0

Peritumoral

63

100%/31%

3/16 (19)

Boughey 2006a [8]

21

12/5/4

Peritumoral

69

100%/46%

1/13 (8)

Karam 2008b [39]

20

11/4/5

Above mastectomy scar

75

15/2

2/13 (15)

  1. aIncluded into the review by Palit et al.
  2. bRe-SLNB after previous mastectomy
  3. cTracer injection at the axillary aspect of the recurrence site in the breast
  4. dTracer injection sub- or intracutaneously over the tumor